Breakthrough Immunotherapy Extends Lives in Multiple Myeloma Patients
A new FDA-approved treatment called Carvykti, a CAR T-cell therapy developed by Legend Biotech in New Jersey, offers a potential 'functional cure' for multiple myeloma, significantly extending remission periods and improving quality of life for patients like Carmen Phaneuf, who has managed to stay in remission for nearly three years after treatment.
